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Objective: Outcomes after surgical repair of abdominal aortic aneurysm (AAA) in patients at high risk remain poorly
defined. We investigated the short-term and long-term results of open repair of infrarenal AAA in a high-risk and
comparison low-risk patient population.
Methods: Conventional open surgical repair of nonruptured infrarenal AAA was performed in 572 consecutive patients
from 1990 to 2000. Patients were considered at high risk if they had one or more of the following criteria: age 80 years
or more, creatinine level 3.0 mg/dL or higher, severe pulmonary insufficiency, severe cardiac dysfunction, or hepatic
failure. A retrospective review was carried out to determine relative risks, perioperative morbidity and mortality, and
long-term survival. A P value of less than .05 was considered statistically significant.
Results: One hundred twenty-eight of the study patients (22%) were at high risk and 444 were at low risk. Patients at high
risk were older (77 versus 69 years; P < .001), were more likely female (26% versus 16%; P < .009), and had larger (mean,
5.9 versus 5.6 cm; P < .024), more symptomatic (20% versus 13%; P < .001) aneurysms. The 30-day operative mortality
rate for the high-risk group was 4.7%, compared with 0.0% (P < .001) in the low-risk group. Overall and major morbidity
rates were 29% and 14% in the high-risk cohort versus 17% (P < .003) and 5% in the low-risk cohort, respectively. The
5-year survival rate was 46% (standard deviation, 5.2%) in the high-risk group versus 74% (standard deviation, 2.6%) in
the low-risk group (P < .001). On multivariate analysis, age 80 years or more (P < .046), creatinine level 3.0 mg/dL or
higher (P < .022), prior stroke (P < .012), and pulmonary dysfunction were significant predictors of poor operative
outcome (30-day mortality and major morbidity), and female gender (P < .035), cardiac dysfunction (P < .004),
creatinine level 3.0 mg/dL or higher (P < .0001), prior stroke (P < .005), and pulmonary dysfunction (P < .0001)
negatively impacted long-term survival rates.
Conclusion: This study shows that open repair of infrarenal AAA in patients at high risk can be performed with relative
safety and with results that offer a benchmark with which endovascular repair can be compared. Poor long-term survival
in this population, however, highlights the importance of patient selection and raises the question of whether repair of
many patients at high risk is warranted. (J Vasc Surg 2003;37:285-92.)
Morbidity and mortality rates after abdominal aortic
aneurysm (AAA) repair have significantly improved over
recent decades. Current single-center series report 30-
day mortality rates for repair of nonruptured aneurysms
ranging from 1.6% to 6.5%,1,2 in large part from im-
proved case selection, operative management, and post-
operative care. Regional and population studies have
indicated higher operative and hospital mortality rates of
between 6% and 8%.2,3 In the current era of endovascular
alternatives, there is an evolving debate as to whether
patients at high risk with an AAA are best treated with
open or endovascular means. There is a common percep-
tion that the less invasive nature of endovascular repair is
particularly suited to those patients at high risk of doing
poorly with traditional open repair. However, concerns
over durability, intermediate-term complications, and
need for reintervention with endolumenal therapy has
tempered some of this initial enthusiasm.4
Important to this debate is a clear understanding of
what constitutes “high risk” for this patient population,
definitions of which vary widely in the literature. Also
needed is a better comprehension of the short-term and
long-term outcomes of patients at high risk undergoing
AAA repair, either with open or endovascular means, and
more insight into the natural history of both treated and
untreated patients at high risk with AAA. In three series of
patients at high risk treated nonoperatively, 3-year survival
rates ranged between 17%5 and 30%,6,7 with a significant
majority of deaths from causes unrelated to the aneurysm.
In comparison, a recent review of the endovascular experi-
ence at one high-volume center reporting on a series of
patients predominantly at high risk found a 37% 5-year
survival rate,8 further underscoring the impact of comorbid
disease on patients with aneurysms. In this study, we
sought to investigate the short-term and long-term out-
comes of conventional open repair of infrarenal aortic an-
eurysms in patients at high risk and to identify the specific
influence of various risk factors.
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METHODS
All patients undergoing conventional open surgical
repair of an infrarenal aortic aneurysm at our institution
over the 10-year period from January 1, 1990, to Decem-
ber 31, 2000, were identified from a computerized surgical
registry database. Demographic variables, preoperative co-
morbidities, operative details, and postoperative outcomes
were obtained from the database and supplemented from
the hospital computerized medical record system and chart
review. Additional survival data were obtained from the
Social Security Death Index and telephone contact. After
exclusion of ruptured aneurysms, 572 consecutive symp-
tomatic and asymptomatic patients were selected for anal-
ysis and divided into either high-risk or low-risk groups.
Patients were defined as being at high risk if they had one or
more of the following criteria: age 80 years or more, serum
creatinine level 3.0 mg/dL or more, pulmonary insuffi-
ciency (defined as a requirement for home oxygen, forced
expiratory volume in 1 second  20% predicted, or forced
expiratory flow at 25% to 75% of vital capacity  20%
predicted), cardiac dysfunction (defined as left ventricular
ejection fraction  20%, recent [within 6 weeks] or recur-
rent symptomatic congestive heart failure as documented
by an attending cardiologist, symptomatic aortic valvular
stenosis, severe unreconstructable coronary artery disease
with or without unstable angina, unstable angina, or inter-
mittent symptomatic ventricular ectopy poorly controlled
with medication or pacemaker therapy), or hepatic failure
defined as biopsy-proven Child’s class C cirrhosis (Table I).
The high-risk and low-risk groups were compared for
comorbidities, demographic and operative variables, length
of stay, major and overall postoperative morbidity, periop-
erative mortality, and long-term survival. Major morbidity
was defined as the 30-day occurrence of myocardial infarc-
tion, renal failure (defined as an increase of at least twice the
preoperative creatinine level or need for dialysis), pneumo-
nia, pulmonary embolism, or stroke. The primary endpoint
was the occurrence of a major complication or death within
30 days of operation. Additional outcomes included overall
complications, 2-month and 6-month mortality, and
5-year cumulative survival. Statistical significance was de-
termined for the impact of individual high-risk factors and
the combination of more than one high-risk factor. A
second analysis of the entire study group was performed to
determine risk factors from a wide range of preoperative
variables with univariate and multivariate analysis for the
primary endpoint and time to medium survival. A subgroup
analysis was determined for varying levels of age, creatinine
level, and cardiac disease. Categoric variables were com-
pared with the Fisher exact test, and continuous variables
were compared with the t test. Survival was compared with
the Kaplan-Meier log-rank test. Logistic regression and
Cox analyses were calculated with SAS Version 8.2 (SAS
Institute, Inc, Cary, NC). A P value of .05 or less was
considered to represent statistical significance.
RESULTS
One hundred twenty-eight of the study patients (22%)
were considered at high risk and 444 (78%) at low risk. The
distribution of risk factors in the high-risk cohort is indi-
cated in Table I. Profiles of the patients at high and low risk
are listed in Table II. Eighty-six of the patients (67%) at
high risk had a single “high-risk” risk factor, 39 (31%) had
two risk factors, and three (2%) had three risk factors.
Cardiac dysfunction was predominant in patients with
more than one risk factor, present in 92% of patients with
two risk factors, and in all three of the patients with three
risk factors. Patients at high risk were significantly older (77
Table I. High-risk criteria for patients undergoing AAA
repair
Variable No.
Age  80 y 58 (45%)
Creatinine level  3.0 mg/dL 11 (9%)
Pulmonary dysfunction Home oxygen 21 (16%)
FEV1  20% predicted
FEF25-75  20%
predicted
Cardiac dysfunction LVEF  20% 79 (62%)
Recent or recurrent CHF
Symptomatic aortic
stenosis
Unreconstructable CAD
Unstable angina
Severe ventricular ectopy
Hepatic dysfunction Biopsy-proven Child’s class
C cirrhosis
1 (0.8%)
FEV1, Forced expiratory volume in first second; FEF25-75, forced expiratory
flow between 25% and 75% of vital capacity; LVEF, left ventricular ejection
fraction; CHF, congestive heart failure; CAD, coronary artery disease.
Table II. Characteristics of patients at high and low risk
undergoing AAA repair
High
risk
Low
risk P value
Demographics
Age (mean; y) 77 69 <.001
Gender, male 95 (74%) 374 (84%) <.009
Size
mean (cm) 5.9 5.6 <.024
median (cm) 5.8 5.3
range (cm) 3.0-9.0 2.5-12
Asymptomatic 92 (72%) 376 (85%) <.001
Comorbidities
Diabetes mellitus 13 (10%) 35 (8%) .414
Smoking 35 (27%) 154 (35%) .120
Hypertension 69 (54%) 244 (55%) .834
Cholesterol (mean; mg/dL) 204.7 209.3 .342
Coronary artery disease* 82 (64%) 206 (46%) <.001
Prior CABG 31 (24%) 91 (21%) .365
Prior stroke 16 (13%) 29 (7%) <.027
Peripheral vascular disease 12 (9%) 20 (5%) <.035
Operative details
Tube graft 84 (66%) 300 (68%) .680
EBL (mean; mL) 1328 1158 .121
*Includes coronary artery disease at levels insufficient to qualify for high risk.
CABG, Coronary artery bypass grafting; EBL, estimated blood loss.
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versus 69 years; P  .001), more likely female (26% versus
16%; P  .009), and more likely symptomatic (28% versus
15%; P  .001) on presentation. Symptoms were predom-
inately abdominal or back pain but included atheroemboli
to the lower extremity in 11 patients at low risk and in 12
patients at high risk. The mean size of the aneurysm in the
high-risk group was 5.9 cm compared with 5.6 cm in the
low-risk group (P  .024).
Outcomes analysis. Overall mortality within 30 days
occurred in six of the 572 patients (1.0%). All six were
patients at high risk, for a high-risk operative mortality rate
of 4.7% (standard deviation [SD], 1.9%) and a low-risk
operative mortality rate of 0.0% (P  .001). The 2-month
and 6-month mortality rates were 4.7% and 7.8% for the
high-risk group and 1.1% and 2.2% for the low-risk group.
The in-hospital mortality rate was 5.5% for patients at high
risk and 0.2% for patients at low risk. The cause of 6-month
mortality in the high-risk cohort was multisystem failure in
four patients (40%), arrhythmia in three patients (30%),
pneumonia in two patients (20%), and unknown in one
patient. The overall and major morbidity rates were 29%
and 14% in the high-risk population versus 17% (P .003)
and 5% (P  .001) in the low-risk group, respectively.
Details of major and minor postoperative morbidity are
listed in Table III. Mean length of stay was 14.3 days
(range, 5 to 199 days) in the high-risk group versus 10.0
days (range, 4 to 127 days) in the low-risk group (P 
.001). When outliers (3 weeks) were removed, length of
stay was reduced to 10.1 days for the high-risk group and
8.4 days for the low-risk group (P  .001).
The overall 5-year cumulative survival rate was 68%
(SD, 2.4%). The 5-year survival rate was 46% (SD, 5.2%) in
the high-risk group and 74% (SD, 2.6%) in the low-risk
group (P  .001; Fig 1). The mean follow-up time was
47.3 months, with a median of 42.8 months and a range of
0 to 149 months. Fifteen percent of patients were lost to
follow-up, defined as last patient contact more than 18
months previously. Thirty-one percent of the patients in
the study died during follow-up, including 68 of the 128
patients at high risk (53%) and 111 of the 444 patients at
low risk (25%). Malignant disease (25 patients; 14%), car-
diac events (15 patients; 8%), multiorgan failure (five pa-
tients; 3%) and sepsis (four patients; 2%) were the leading
causes of late death in the 54 patients for whom cause of
death information is available.
Risk factor analysis. The operative mortality rate was
3.6% (SD, 2.0%) in those patients with only a single high-
risk factor (P  .001 of low-risk group) and 7.7% (SD,
4.4%) in those with two high-risk factors (P .001). None
of the three patients with three high-risk factors died in the
perioperative period. The major morbidity rate was 10% in
those patients with a single high-risk factor, 15% in those
with two high-risk factors, and 66% in those with three
high-risk factors (P  .039 for one versus three high-risk
factors). The 5-year survival rate was 43% (SD, 6.7%) in
those with one high-risk factor and 40% (SD, 9.6%) in those
with two high-risk factors (P  not significant). All three
patients with three high-risk factors died within 3 years of
operation (Fig 2). Outcome as a function of each high-risk
factor is detailed in Table IV.
In univariate analysis of both high-risk and low-risk
groups over the range of preoperative variables examined
with an endpoint of either a major complication or 30-day
death, significant predictors of a poor outcome were age 80
years of more (P  .0034), cardiac dysfunction (P
 .0016), creatinine level 3.0 mg/dL or higher (P 
.0001), and prior stroke (P  .0082). Aneurysm size was
also a significant variable (P  .032, t test), while female
gender, diabetes, a history of smoking, hypertension, and
the presence of symptoms were not statistically significant
factors. In multivariate analysis with a logistic regression
model, age 80 years or more (P  .046; odds ratio [OR],
2.5; 95% CI, 1.0 to 6.2), creatinine level 3.0 mg/dL or
higher (P  .022; OR  6.8; 95% CI, 1.3 to 35.1), prior
stroke (P  .012; OR  3.2; 95% CI, 1.3 to 7.7), and
pulmonary dysfunction (P .011; OR 5.2; 95% CI, 1.5
to 18.4) were significant, and cardiac dysfunction and
aneurysm size were not (Table V).
Similar results were found with Kaplan-Meier analysis
to determine which variables impacted on time to median
survival after AAA repair, where age 80 years or more (P
 .0004), female gender (P  .026), cardiac dysfunction
(P  .0001), creatinine level 3.0 mg/dL or higher (P
 .0001), prior stroke (P  .0015), and pulmonary dys-
function (P  .0001) were all statistically significant pre-
dictors. Of these, all but age 80 years or more remained
significant on multivariate analysis with the Cox model
(Table V).
Additional subgroup analysis was performed for symp-
tom status, age, and cardiac and renal dysfunction variables.
The 30-day mortality and 5-year survival rates of symptom-
Table III. Postoperative morbidity in patients at high
and low risk undergoing open AAA repair
High
risk
Low
risk P value
Major morbidity
Myocardial infarction 1 (1%) 6 (1%) .605
Renal failure 9 (7%) 4 (1%) .001
Pneumonia 13 (10%) 17 (4%) .005
Other Morbidity
Arrhythmia 16 (13%) 27 (6%)
Congestive heart failure 2 (2%) 1 (1%)
Peripheral emboli 2 (2%) 4 (1%)
Protracted ileus 4 (3%) 24 (5%)
Gastrointestinal bleed 1 (1%) 3 (1%)
Pancreatitis 2 (2%) 2 (1%)
Hemorrhage requiring
reoperation
3 (2%) 2 (1%)
Wound infection 2 (2%) 6 (1%)
Wound dehiscence 5 (1%)
Deep venous thrombus 4 (1%)
Coagulopathy 1 (1%)
Hematoma 3 (1%)
Colon ischemia 1 (1%)
Hepatic failure 1 (1%)
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atic patients were not significantly different than those of
asymptomatic patients (1.0% versus 1.1%; P  .93; 60%
versus 69%; P .07, respectively). Neither moderate levels
of coronary artery disease (insufficient to qualify for high-
risk cardiac dysfunction) nor prior coronary bypass grafting
significantly impacted outcome. Patients 60 to 79 years of
age had significantly decreased aneurysm size (P  .01),
length of stay (P .001), and major morbidity (P .006)
and increased 5-year survival rate (70% versus 48%; P
 .006) compared with patients 80 years or more of age.
Fig 1. Five-year cumulative survival rate after infrarenal AAA repair in patients at high and low risk.
Fig 2. Five-year cumulative survival rate after infrarenal AAA repair in patients with one, two, and three high-risk
factors.
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Finally, patients with a creatinine level of between 2.0 and
3.0 mg/dL had a 5-year survival rate of 45% compared with
11% for those with a creatinine level of 3.0 mg/dL or
higher and 69% for those with creatinine level of less than
2.0 mg/dL.
DISCUSSION
Although numerous studies have documented the im-
proved results of elective surgical repair of AAAs in recent
decades,1,2 less is known about the fate of patients consid-
ered at higher risk for traditional surgery. The issue is
compounded by frequently vague and widely varying defi-
nitions of the term “unfit” encountered in the literature. A
better understanding of this subset of patients is warranted
given the aging of the population, the increasing incidence
rate of AAAs, and the availability of endovascular alterna-
tives to traditional repair of AAA. The decision on whether
or when to operate on patients at high risk will ultimately
depend on the risk of surgery weighed against the risk of
conservative management and the risk of alternative inter-
ventions.
The criteria chosen for high-risk classification in this
study were selected on the basis of prior reports of risk
stratification in the general and vascular surgical literature.
They incorporate many of the major components of previ-
ously established operative risk assessment schemas, for
example, those of The American Society of Anaesthesiolo-
gists Physical Class9 system. An additional risk stratification
model influencing our choice of criteria was described by
Steyerberg et al,10 who established renal impairment (de-
fined as a creatinine level  1.8 mg/dL), congestive heart
failure, electrocardiographic evidence of cardiac ischemia,
pulmonary insufficiency (defined broadly as including
chronic obstructive pulmonary disease, emphysema, dys-
pnea, or prior lung surgery), and female gender as the
strongest adverse risk factors after elective repair of AAA.
Similar high risk markers were identified in the Canadian
Aneurysm Study,11 the United Kingdom Small Aneurysm
Trial,12 and other AAA studies of open surgical repair.13-15
Several endovascular reports have invoked less strict criteria
to define high risk.16,17 Because the primary goal of the
study was to determine whether patients at high risk could
safely undergo open surgical repair, we chose the more
stringent of the criteria typically cited in other reports.
The major finding in this study was that of an operative
mortality rate of 4.7% in the patients at high risk. Our
Table IV. Short-term and long-term outcome in patients at high risk per high risk variable
High-risk
factor
No.
total*
No.
alone†
No.
shared‡
Major
morbidity
Operative
mortality
total§
Operative
mortality
alone
5-year
survival
total
5-year
survival
alone
Age  80 y 58 36 22 17% 1.7% 2.8% 48% 50%
Cardiac 79 40 39 14% 6.3% 5.0% 46% 51%
Pulmonary 21 11 10 10% 4.8% 0.0 34% 44%
Renal 11 1 10 36% 18.2% 0.0 11%
Hepatic 1 0 1 0.0 0.0 0.0 0.0
*Total number of patients with this high-risk factor.
†Number of patients with this risk factor alone.
‡Number of patients with this as one of two or three high-risk factors.
§Percentage of total number of patients with this high-risk factor who died within 30 days of AAA repair.
Table V. Univariate and multivariate analysis for operative outcome and time to median survival on all patients
undergoing infrarenal AAA repair (P values)
Operative mortality and major morbidity Time to median survival
Univariate* Multivariate† Univariate‡ Multivariate§
Age  80 y .0034 .046 .0004
Creatinine level  3.0
mg/dL
.0001 .022 .0001 .0001
Prior stroke .0082 .012 .0015 .005
Pulmonary dysfunction .069 .011 .0001 .0001
Cardiac dysfunction .0016 .0001 .004
Aneurysm size¶ .032
Female gender .026 .035
*Fisher’s exact test.
†Logistic regression model.
‡Kaplan-Meier log-rank test.
§Cox model.
See text for OR and CI.
¶t test.
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results show that patients at high risk can tolerate tradi-
tional open surgery with an acceptable degree of short-term
mortality and morbidity, indeed with rates approaching
those of published cohorts not at high risk. There were no
perioperative deaths in the low-risk group, and the low
2-month, 6-month, and hospital mortality rates were reas-
suring that the relative safety of surgery was not limited to
the first 30 days.
The 30-day mortality rate was found to more than
double in patients with more than one high-risk factor. The
increase was most marked for those patients with severe
renal dysfunction, where an 18% mortality rate was seen.
This result is consistent with an extensive literature docu-
menting the negative impact of renal failure on operative
outcome after aortic surgery.12,18,19 The finding of in-
creased surgical mortality in patients with aneurysms with
prior stroke11,20 and combined pulmonary and cardiac
disease21 is also in agreement with previous reports.
Gender, which has been an inconsistent high-risk
marker for aneurysm repair in the literature,10,12,19,22,23
was not predictive of increased perioperative mortality but
was associated with a reduced time to median survival in
this review. Advanced age, conversely, was associated with a
modest increase in operative mortality compared with pa-
tients at low risk and was not a significant predictor of a
lower long-term survival, supporting previous asser-
tions14,24 that the presence of this risk factor alone should
probably not preclude AAA repair.
The 30-day mortality rate found herein compares fa-
vorably with several older reports of patients at high risk
undergoing elective AAA repair (Table VI).6,13,25 In the
only more recent series identified, Morishita et al26 re-
ported a 4.2% operative mortality rate in a cohort of 110
patients, with high-risk criteria similar to our own. The rate
rose from 2% in patients with a single risk factor to 6% in
those with two to 11% in those with three risk factors,
comparable with our own findings.
Of particular note is that the short-term mortality rates
found in this study are comparable with or are better than
those reported for patients with AAA at high risk treated
with endovascular grafts (Table VI). The recently updated
Eurostar experience detailed a 4.8% and 5.3% operative
mortality rate for patients considered unfit for open surgery
or unfit for general anesthesia, respectively.27 Importantly,
in a large, single-center experience over a 9-year span
treating predominantly patients at high risk, the 30-day
mortality rate was 8.5% with endolumenal repair.8 Similar
or higher rates have been found by others.28,29 With a less
stringent definition of high risk, Chuter et al17 reported a
favorable 3.4% operative mortality rate in the first 58 pa-
tients at high risk treated with endovascular grafting and
0.0% in the subsequent 58 patients, supporting claims that
further experience with endovascular technology will lead
to improved results.
One of the most important findings in this study was
that of the poor long-term survival of the patients at high
risk. The durability of traditional open repair of AAAs is
well documented,30,31 with acceptable long-term survival
rates and few long-term complications the rule. Collating
the published large institutional series, Ernst1 found an
average 5-year survival rate of 67% after elective open AAA
repair, similar to the 74% seen with patients at low risk in
this study.
In contrast, the 5-year survival rate of our high-risk
cohort was 46%, raising the question of whether surgery is
ultimately indicated in many of these patients. Long-term
survival was significantly reduced as the number of risk
factors increased but was also below 50% when any one of
the five preselected high-risk factors were present in isola-
tion (Table IV). The longevity of patients with either renal
(11% 5-year survival rate) or pulmonary dysfunction (34%
5-year survival rate) was particularly dismal.
Further information relevant to the optimal manage-
ment of patients with AAA at high risk can be found in
outcomes studies of such patients managed nonoperatively.
Conway et al,5 for example, recently reported a remarkable
17% 3-year survival rate in 106 patients considered at too
high risk for elective aneurysm repair. Szilagyi, Elliott, and
Smith6 and Jones, Cahill, and Gardham7 found 3-year
survival rates of 30% and 26%, respectively, and Perko et
al32 reported a 15% 5-year survival rate in similar cohorts of
patients at high risk treated conservatively. The clear ma-
jority of these patients died of causes unrelated to their
aneurysm, and only a minority would have potentially
benefitted from surgery. The accruing endovascular data on
the long-term outlook of patients with AAA at high risk is
equally as sobering.27,28 Of particular note is the finding of
Table VI. Outcomes in patients with AAA at high risk undergoing open or endovascular repair
Open repair Endovascular repair
Study Year No. Mortality Study Year No. Mortality
Szilagyi et al6 1972 29 16.7% Buth et al27 2002 399/155 4.8%*/5.3%†
Bernstein et al13 1984 99 4.9% Ohki et al8 2001 206 8.5%
Hollier et al25 1986 106 5.7% Zannetti et al28 2001 26 8.0%
Morishita et al26 1991 110 4.2% Chuter et al17 2000 1st 58 3.4%
2nd 58 0.0
Walker et al29 1999 140 16%
*Patients “unfit” for open surgery.
†Patients “unfit” for general anesthesia.
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Ohki et al8 of a 37% 5-year survival rate in their predomi-
nantly high-risk endovascular AAA series.
Although the data for this review were collected in a
prospective registry, the study is limited by its retrospective
nature. Additional deficits of the report include the inher-
ent selection bias represented by patients determined to be
“nonoperative” over the course of the study period and the
absence of comparison outcome data for these patients, a
15% rate of patients lost to follow-up, and low numbers of
certain subsets of patients precluding meaningful statistical
subanalysis.
In this report, we have shown that AAA patients at high
risk as well as low risk can undergo open surgical repair
safely and with results that represent a standard to which
any alternative therapy may be compared. It is anticipated
that better results will follow improvements in endovascular
technology and progression over the learning curve. Fur-
thermore, the results of several planned randomized trials
comparing open repair with endovascular repair in Europe
and the United States in patients both at normal risk and at
high risk should shed additional light on the optimal man-
agement of patients with aneurysms. However, taken as a
whole, the cited literature combined with our own findings
suggest that patients with AAAs and significant comorbid
disease will fare poorly in the long run, whether the aneu-
rysm is fixed or not and whether operative or endovascular
means are used for repair. As such, they reinforce the
importance of patient selection and the need for caution in
offering repair to those patients with limited life expect-
ancy.
We thank Julie Lombara for help with database man-
agement and statistical analysis. Statistical analysis was per-
formed by Peter Gaccione (The Harvard School of Public
Health) and Julie Lombara.
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DISCUSSION
Dr Jacob Buth (Eindhoven, Netherlands). You started to
point out that there are variable definitions on unfit patients and, of
course, this makes comparison with other studies quite difficult.
Then you started to point out what your criteria were. And I think
it is sensible to realize that your criteria are completely incompara-
ble, for instance, with the criteria of the EVAR II trial in England
where they compare the outcome of conservative treatment and
endovascular treatment in unfit patients. These are totally different
unfit categories. That kind of unfit patients would not tolerate an
open procedure.
The same for our recently published Eurostar series, we de-
fined unfit as unfit for open procedure. I think your range of your
inclusion criteria is very, very wide. It ranges from patients with
pulmonary dysfunction on home oxygen and patients with a
slightly diminished FEV1 of 75%, which makes it difficult to use
your criteria for an unequivocal definition of what is an unfit
patient.
One of the definitions, of your definitions, should have been
that there should be an effort to come up with unequivocal criteria
for what patient is unfit. Is it unfit for open surgery or is it slightly
unfit?
Dr Matthew T. Menard. I fully agree with your overall
concept. The definition that we used for pulmonary dsyfunction
was actually an FEV1 of less than 20%, not 75%, and so was in fact
a very strict criterion. In the literature, I found a wide range of
high-risk values cited. For example, I often saw an FEV1 of less
than 50%, or an ejection fraction of less than 50% or creatinine
cutoffs of more than 1.5. In my own view, the premise of the paper
was to try to determine whether patients so labeled as unfit are
indeed truly unsuitable for surgery, that is, how they actually did
with surgery. For that reason, I specifically tried to choose the most
strict criteria of the range considered, for example an ejection
fraction of less than 20%. I strongly share your desire for standard-
ized high-risk criterion that could be utilized and adhered to in
future studies.
Dr Clifford J. Buckley (Temple, Tex). Did you have results
of quality-of-life surveys on these patients after they were subjected
to surgical repair? The reason I ask is that survival is one thing,
quality of life is another issue. We are looking at that now. Quality
of life may not be the same after open surgical repair as it was prior
to undergoing the procedure.
Dr Menard. I could not agree more. I would actually encour-
age everyone to do a retrospective review of their open AAA
experience.
I contacted about half of the surviving patients. As follow-up
was not complete and it was not a rigorous data set, I did not
include it in the manuscript or the presentation. However, what I
did find was a nearly 100% rate of both patient satisfaction and
return to full function in those patients I did contact. Again, it was
an incomplete survey and I do not have the opinions of all of the
patients, including obviously those that died, who I imagine would
probably be a bit less enthusiastic about their repair. But those I did
speak with were very pleased with their operation and long-term
outcome.
Dr John W. Hallett, Jr (Bangor, Me). I have several specific
questions about preparing these patients for surgery and managing
them afterward. How many of your patients with heart disease had
preoperative coronary revascularization? Do you use a standard
transabdominal surgical approach? Do you use epidural analgesia
postop? Are there any other adjuncts that you would advise us to
use to get these great results?
Dr Menard. Thank you for your questions, Dr Hallett. We
did look at the influence of coronary artery bypass grafting. About
50% of all patients had some degree of coronary artery disease, with
the majority having what I would classify as “non-high-risk”
coronary artery disease. Twenty-one percent had prior coronary
artery bypass grafting, a quarter of which were within 6 months of
their AAA repair. Neither the presence of non-high-risk cardiac
dysfunction nor prior coronary bypass grafting had a statistically
significant impact on outcome.
We do use epidural anesthesia liberally. We also typically tailor
the surgical approach to the anatomic situation at hand, employing
whichever of the transperitoneal and retroperitoneal incisions
seems most appropriate for a given patient.
Dr Jean-Pierre Becquemin (Creteil, France). We published
in the European Journal of Vascular Surgery 2 years ago a similar
study of 477 patients, and we came to similar conclusions as yours.
But we also looked at the anatomic distribution of the aneurysm,
and we were able to find that when there was bilateral hypogastric
aneurysms the postoperative mortality was increased by almost a
threefold. Have you looked at that in your series? The subsequent
question is, is it possible that in your high-risk patients there could
be less patients with bilateral hypogastric artery aneurysms than in
your good-risk patients, which may bias the results?
Dr Menard. I did not look specifically at the incidence or
influence of hypogastric artery aneurysms. What I can tell you is
that both cohorts did have a statistically similar percentage of
bifurcated and tube grafts placed.
Dr John H. N. Wolfe (London, United Kingdom). This is
the sort of excellent results we have learned to expect from the
Brigham.
What I would like to ask you is whether you have altered your
practice as a result of these results? Because you have shown that in
the high-risk group most of them are dead at 3 years, or over half
of them. And we now know that in everything except very large
aneurysms, the prospects are more benign than we thought. And
therefore, if you have got a 60% mortality at 3 years, following
successful surgery, in an aneurysm that is not 7 cm, perhaps we
should be considering a conservative approach in some of those
patients.
Dr Menard. I agree, and that is the obvious implication of
the paper. There is some recent literature on patients that are not
offered either open or endovascular repair, and the long-term
survival is rather dismal in those studies. This would emphasize
your conclusion that in certain high-risk patients, such as those
with renal failure as one of the comorbid presenting variables, we
should be a bit less liberal in repairing these patients than we have
been to date.
Dr Wolfe. Specifically, has this altered your practice yet at the
Brigham? Have you altered your practice?
Dr Menard. The practice standards at the Brigham are well
entrenched. However, we have shown that even though we can
successfully get high-risk patients through their operation, this
does not mean that we should operate on every aneurysm patient
we see. The poor long-term outcome of many of these patients will
certainly be considered in future practice.
Dr Hero Van Urk (Rotterdam, Netherlands). My question
is, did you use  blockers for the patients with a high cardiac risk?
As we have shown, there is a reduction of perioperative cardiac
events on patients who used  blockers of tenfold and the long-
term morbidity decreased threefold with the use of  blockers. So
what was your regimen for these patients?
Dr Menard. We have the luxury at our hospital of having a
vascular medicine service that sees all of our patients. The over-
whelming majority, if not all, are put on  blockers unless contra-
indicated. Perhaps that is one reason why cardiac dysfunction was
not a significant variable in multivariate analysis of operative mor-
tality.
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